Loading…
Allergy Testing Access Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Allergy Testing Access Act of 2021 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2022 · fourth_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021. Medicare coverage for small cell lung cancer genetic test.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement & regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932, S.4449/H.R.8188, CY23 CLFS); Precision Medicine (H.R. 6000/H.R. 5989); COVID preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463, P.L. 117-328); Future pandemic preparedness & response (S. 3799, H.R. 7152/S. 3534, H.R. 3635/S. 1974, P.L. 117-328); User Fees Reauthorization (S. 4328/H.R. 7667); ARPA-H (S. 3819/H.R. 5585); Biotechnology and biomanufacturing.
Client expense: $450,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).
Client expense: $870,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · third_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).
Client expense: $580,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · second_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine (CURES 2.0/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534); Cancer Moonshot 2.0; Health Equity.
Client expense: $740,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · first_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · fourth_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine (CURES 2.0/H.R. 5989); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · fourth_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics. H.R. 5993, MEDS in America Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128); Precision Medicine (CURES 2.0); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128); Precision Medicine (CURES 2.0); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $50,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · second_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · second_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies; Precision Medicine; COVID-19 preparedness products and services; K-12 COVID-19 school testing programs; Employer COVID-19 testing programs; Genetic surveillance & viral sequencing (S. 236/H.R. 791); Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Drug testing regulations; Future pandemic preparedness and response.
Client expense: $1,020,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
| Democratic |
| MN |
| Ann M. Kuster | Democratic | NH |
| Bobby L. Rush | Democratic | IL |
| Brian K. Fitzpatrick | Republican | PA |
| Darren Soto | Democratic | FL |
| Diana DeGette | Democratic | CO |
| Don Bacon | Republican | NE |
| Fred Upton | Republican | MI |
| G. K. Butterfield | Democratic | NC |
| H. Morgan Griffith | Republican | VA |
| James A. Himes | Democratic | CT |
| Jamie Raskin | Democratic | MD |
| Joseph D. Morelle | Democratic | NY |
| Kathy Castor | Democratic | FL |
| Lisa Blunt Rochester | Democratic | DE |
| Paul Tonko | Democratic | NY |
| Pete Aguilar | Democratic | CA |
| Raja Krishnamoorthi | Democratic | IL |
| Rick Larsen | Democratic | WA |
| Scott H. Peters | Democratic | CA |
| Seth Moulton | Democratic | MA |
| Suzanne Bonamici | Democratic | OR |
| Terri A. Sewell | Democratic | AL |
| Tom O’Halleran | Democratic | AZ |